Nova EYE Medical Ltd Asset Resilience Ratio
Nova EYE Medical Ltd asset resilience ratio. Nova EYE Medical Ltd (EYE) has an Asset Resilience Ratio of 11.08% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Nova EYE Medical Ltd (EYE) liquidity interval to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Nova EYE Medical Ltd (2001–2025)
Asset resilience ratio of Nova EYE Medical Ltd from 2001 to 2025. This chart shows how Nova EYE Medical Ltd's Asset Resilience Ratio has changed over time. Read Nova EYE Medical Ltd total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Nova EYE Medical Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see EYE current and non-current assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$2.62 Million | 11.08% |
| Short-term Investments | AU$0.00 | 0% |
| Total Liquid Assets | AU$2.62 Million | 11.08% |
Asset Resilience Insights
- Moderate Liquidity: Nova EYE Medical Ltd has 11.08% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Nova EYE Medical Ltd Industry Peers by Asset Resilience Ratio
Compare Nova EYE Medical Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
Ningbo David Medical Device Co Ltd
SHE:300314 |
Medical Devices | 5.11% |
|
Affluent Medical SAS
PA:AFME |
Medical Devices | 0.03% |
|
MODULIGHT OY EO 1
F:78W |
Medical Devices | 15.99% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 2.12% |
|
Promimic AB
ST:PRO |
Medical Devices | 8.62% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Memphasys Ltd
AU:MEM |
Medical Devices | 0.00% |
Nova EYE Medical Ltd Asset Resilience Ratio by Year (2001–2025)
Nova EYE Medical Ltd asset resilience ratio by year from 2001 to 2025. The table below shows the annual Asset Resilience Ratio data for Nova EYE Medical Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-06-30 | 19.07% | AU$5.05 Million ≈ $3.58 Million |
AU$26.50 Million ≈ $18.75 Million |
-1.51pp |
| 2024-06-30 | 20.58% | AU$6.15 Million ≈ $4.35 Million |
AU$29.88 Million ≈ $21.14 Million |
-3.85pp |
| 2023-06-30 | 24.44% | AU$7.42 Million ≈ $5.25 Million |
AU$30.36 Million ≈ $21.48 Million |
+2.60pp |
| 2022-06-30 | 21.84% | AU$8.00 Million ≈ $5.66 Million |
AU$36.62 Million ≈ $25.91 Million |
-20.55pp |
| 2021-06-30 | 42.39% | AU$17.80 Million ≈ $12.60 Million |
AU$41.99 Million ≈ $29.71 Million |
-39.54pp |
| 2020-06-30 | 81.93% | AU$95.65 Million ≈ $67.68 Million |
AU$116.74 Million ≈ $82.60 Million |
+66.54pp |
| 2019-06-30 | 15.39% | AU$15.37 Million ≈ $10.88 Million |
AU$99.89 Million ≈ $70.68 Million |
-6.91pp |
| 2018-06-30 | 22.29% | AU$23.07 Million ≈ $16.32 Million |
AU$103.47 Million ≈ $73.21 Million |
+11.61pp |
| 2017-06-30 | 10.68% | AU$9.24 Million ≈ $6.54 Million |
AU$86.54 Million ≈ $61.23 Million |
+10.30pp |
| 2008-06-30 | 0.38% | AU$275.00K ≈ $194.58K |
AU$71.94 Million ≈ $50.90 Million |
+0.12pp |
| 2007-06-30 | 0.26% | AU$167.00K ≈ $118.16K |
AU$63.69 Million ≈ $45.06 Million |
+0.16pp |
| 2006-06-30 | 0.10% | AU$46.00K ≈ $32.55K |
AU$46.48 Million ≈ $32.88 Million |
-42.45pp |
| 2001-06-30 | 42.54% | AU$487.42K ≈ $344.88K |
AU$1.15 Million ≈ $810.63K |
-- |
About Nova EYE Medical Ltd
Nova Eye Medical Limited designs, develops, manufactures, markets, and sells surgical devices for the treatment of glaucoma in Australia, the United States, Europe, the Asia Pacific, and internationally. The company operates through Glaucoma Surgical Devices and AlphaRET segments. It offers 2RT, a proprietary laser technology to treat patients in early and intermediate age-related macular degener… Read more